ZAMMSA, ZAMRA clarify on ‘defective’ antibiotics from Danish firm
Published On January 4, 2024 » 1305 Views» By Times Reporter » HOME SLIDE SHOW, SHOWCASE
 0 stars
Register to vote!
. Chifungula

By CHUSA SICHONE –
THE Zambia Medicines and Medical Supplies Agency (ZAMMSA) and Zambia Medicines Regulatory Authority (ZAMRA) say Denmark’s Missionpharma has not produced evidence to dispute that the antibiotic, Erythromycin Stearate BP tablets it supplied were defective.
ZAMMSA chairperson Anna Chifungula said Missionpharma would have to replace the Erythromycin Stearate 250mg BP tablets if it failed to present results which were different from those that ZAMRA produced indicating that some batches of the antibiotic did not meet the quality standard.

Read more

Share this post
Tags

About The Author